Upper gastrointestinal bleeding is one of the common complications of cirrhosis and includes conditions such as vomiting blood, black stools, and decreased blood pressure. Through gastric coronary vein embolization, partial splenic artery embolization, transjugular intrahepatic portal vein shunt (TIPS) and other treatments, the hemostasis rate is over 95% for patients with emergency bleeding, and for cirrhotic patients with a history of bleeding it can prolong the cycle of rebleeding significantly, or even can be cured radically. The advantages of this technology lie in the advantages of safety, small injury, fast recovery, good effect of minimally invasive, high hemostasis rate, and a wide range of adapted population, which can significantly improve the survival period and quality of life of patients.